Posted by Linda Flegge on Dec 28th, 2024
Trevi Therapeutics, Inc. (NASDAQ:TRVI – Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 4,660,000 shares, a growth of 230.5%...
More of this article »